The Influence of Infant Feeding Type on Preterm Infant's Intestinal Microbiome
NCT ID: NCT04972214
Last Updated: 2021-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2021-05-17
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metagenomic Analysis of Gut Microbiome in Preterm
NCT03235635
Gut Microbiota of Preterm Infants and Full-term Infants at Early Life
NCT03373721
Association of Gut Microbiome With Neonatal Complications and Neurodevelopment in Preterm Infants
NCT03841994
Early Iron Exposure on the Gut Microbiota in Young Infants
NCT03828708
Is There a Microbiome Associated With Poor Growth in Preterm Infants?
NCT03761498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of study is to determine the impact of feeding type on gut microbiome of very preterm infants admitted in a neonatal intensive care unit (NICU). Meconium and the additional 2 fecal samples will be collected from preterm infants. Fecal samples will be collected every 14 days, during 28 days, from diapers into sterile tubes. DNA will be extracted from fecal samples and different bacterial genus and species will be analyzed.
The type of infant feeding (breast milk or preterm formula) is recorded daily to classify the type of infant feeding received during the 14 days prior to each fecal sample collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Very Preterm Infants
preterm infants were born at gestational age of less than 32 weeks
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major congenital anomalies
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHA University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hye-Rim Kim
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hye-Rim Kim, MD
Role: PRINCIPAL_INVESTIGATOR
CHA Bundang Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHA Bundang Medical center
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-03-062-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.